The post Argus Cognitive’s paediatric autism diagnostic secures FDA clearance appeared first on Medical Device Network.
Argus Cognitive’s paediatric autism diagnostic secures FDA clearance
Argus's Neurora tool is intended to complement clinicians' professional judgement rather than serve as a standalone diagnostic for autism. Argus's Neurora tool is intended to complement clinicians' professional judgement rather than serve as a standalone diagnostic for autism. The exact cause of autism is unknown, but it is thought to be caused by a combination of biological and environmental factors. Credit: Vitalii Vodolazskyi/Shutterstock.com Argus Cognitive’s Neurora has secured US Food and Drug Administration (FDA) clearance, providing clinicians with a tool to support the diagnosis of autism spectrum disorder (ASD) in paediatric patients. Neurora is designed to provide clinicians with objective…
Argus's Neurora tool is intended to complement clinicians' professional judgement rather than serve as a standalone diagnostic for autism.
Source: Medical Device Network